Article citationsMore>>

Mahon, Fx., Rea, D., Guilhot, J., Guillot, F., Huguet, F., Nicolini, F., et al. (2010) Discontinuation of Imatinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Complete Molecular Remission for at Least 2 Years: The Prospective, Multicenter Stop Imatinib (STIM) Trial. Lancet Oncology, 11, 1029-1035.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.